Literature DB >> 1126663

Response of the human cardia sphincter to circulating prostaglandins F2ALPHA and E2 and to antiinflammatory drugs.

J B Dilawari, A Newman, J Poleo, J J Misiewicz.   

Abstract

The effects on intraluminal pressure in the oesophagus, the cardiac sphincter, and the gastric fundus of intravenous prostaglandin F2alpha, E2, And of rectal indomethacin were studies in 41 subjects. Intravenous infusion of prostaglandin F2alpha (0-05 to 0-8 mug kg-minus1) produced marked, dose-related and sustained elevation of cardiac sphincter pressure without significantly affecting oesophageal peristalsis or gastric fundal motility. Sphincteric relaxation during swallowing was prolonged. Plasma gastrin levels were unchanged. Intravenous infusion of PGE2 (0-08 mug kg-minus1 min-minus) inhibited sphincter contractions to serial bolus intravenous injections of pentagastrin (0-1 or 0-2 mug kg-minus 1). Rectal indomethacin (200 mg) resulted in a riseof cardiac sphincter pressure, suggesting that endogenous synthesis of an inhibitory (E-type) prostaglandin was suppressed. The results indicate that prostaglandin E2 may be concerned in the regulation of cardiac sphincter tone in man, whilst prostaglandin F2alpha may be useful in the treatment of gastrooesphageal reflux.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1126663      PMCID: PMC1410986          DOI: 10.1136/gut.16.2.137

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  INDOMETHACIN: STUDIES OF ABSORPTION AND OF THE USE OF INDOMETHACIN SUPPOSITORIES.

Authors:  L P HOLT; C F HAWKINS
Journal:  Br Med J       Date:  1965-05-22

2.  The release of prostaglandin from the oesophagus and the stomach of the frog (Rana temporaria).

Authors:  S Rashid
Journal:  J Pharm Pharmacol       Date:  1971-06       Impact factor: 3.765

3.  Release of prostaglandin E-1 from the rat stomach.

Authors:  A Bennett; C A Friedmann; J R Vane
Journal:  Nature       Date:  1967-12-02       Impact factor: 49.962

4.  Effect of 15(R)15 methylprostaglandin E2 methyl ester on healing of gastric ulcers. Controlled endoscopic study.

Authors:  W P Fung; S M Karim; C Y Tye
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

5.  Prostaglandin inhibition of gastric secretion.

Authors:  P W Ramwell; J E Shaw
Journal:  J Physiol       Date:  1968-03       Impact factor: 5.182

6.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

7.  Indomethacin and aspirin abolish prostaglandin release from the spleen.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

8.  Prostaglandins, aspirin-like drugs and analgesia.

Authors:  S H Ferreira
Journal:  Nat New Biol       Date:  1972-12-13

9.  Mechanism of the lower esophageal sphincter relaxation. Action of prostaglandin E 1 and theophylline.

Authors:  R K Goyal; S Rattan
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

10.  Hormonal regulation of human lower esophageal sphincter competence: interaction of gastrin and secretin.

Authors:  S Cohen; W Lipshutz
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

View more
  10 in total

1.  The effect of intravenous infusions of prostaglandins E-2 and F-2alpha on human gastric function.

Authors:  A Newman; J P de Moraes-Filho; D Philippakos; J J Misiewicz
Journal:  Gut       Date:  1975-04       Impact factor: 23.059

Review 2.  Inflammatory mediators in the oesophagus.

Authors:  G P Morgan; J G Williams
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

3.  The contribution of prostaglandins in the muscle of human isolated small intestine to neurogenic responses.

Authors:  A Bennett; H L Stockley
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

4.  Nonsteroidal antiinflammatory drugs: effect on pyloric sphincter and duodenogastric reflux.

Authors:  J L Pantoja; C Defilippi; J E Valenzuela; A Csendes
Journal:  Dig Dis Sci       Date:  1979-03       Impact factor: 3.199

5.  Effect of an oral beta2-adrenergic agonist on lower esophageal sphincter pressure in normals and in patients with achalasia.

Authors:  A J DiMarino; S Cohen
Journal:  Dig Dis Sci       Date:  1982-12       Impact factor: 3.199

6.  Beneficial effect of indomethacin on acid-induced esophagitis in cats.

Authors:  G L Eastwood; B D Beck; D O Castell; F C Brown; J R Fletcher
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

7.  Estimation and characterization of prostaglandins in the human gastrointestinal tract.

Authors:  A Bennett; I F Stamford; H L Stockley
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

Review 8.  Medical treatment of esophageal motility disorders.

Authors:  H D Allescher; W J Ravich
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

9.  Effects of various prostaglandin synthesis inhibitors on the tone of the lower oesophageal sphincter in man.

Authors:  M Cagossi; M Salgarello; P Patrignani; G Salgarello
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  Effect of cimetidine on the human lower oesophageal sphincter.

Authors:  D H Osborne; J Lennon; M Henderson; G Lidgard; R Creel; D C Carter
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.